biosig_rgb.png
BioSig Technologies to Present at Monaco Growth Forums in London & Monaco
11 avr. 2017 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, April 11, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an...
biosig_rgb.png
BioSig Technologies Completes Private Placement
07 avr. 2017 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, April 07, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address...
biosig_rgb.png
BioSig Technologies Announces Participation in Lafayette College’s InternShift Summer Program
30 mars 2017 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, March 30, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an...
biosig_rgb.png
BioSig Technologies Announces Collaboration with Mayo Clinic Physician Team - Corrected Version
23 mars 2017 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, March 23, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an...
biosig_rgb.png
BioSig Technologies Announces Strategic Partnership with Mayo Clinic
17 mars 2017 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, March 17, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an...
biosig_rgb.png
JACC: Clinical Electrophysiology Manuscript Featuring BioSig’s PURE EP System in Top Five Most Influential of 2016
21 févr. 2017 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, Feb. 21, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to...
biosig_rgb.png
JACC: Clinical Electrophysiology Manuscript Featuring BioSig’s PURE EP System in Top Five Most Influential of 2016
19 févr. 2017 20h00 HE | BioSig Technologies, Inc.
MINNEAPOLIS, Feb. 20, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB:BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an...
biosig_rgb.png
BioSig Technologies Donates to American Heart Association in Sponsorship of American Heart Month
10 févr. 2017 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, Feb. 10, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to...
biosig_rgb.png
BioSig Technologies’ PURE EP System Featured in The Journal of the American College of Cardiology: Clinical Electrophysiology
11 janv. 2017 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, Jan. 11, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary technology platform designed to improve the $4 billion...
biosig_rgb.png
BioSig Technologies Sponsors The 11th International Symposium on Ventricular Arrhythmias
26 sept. 2016 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, Sept. 26, 2016 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a novel cardiac electrophysiology (EP)...